| September 28, 2017 │ Kyoto, Japan Kyoto 2017 Congress, Expansion and Evolution of TDM and CT Post Congress Symposium Sessions |
|||
|
|
|||
| yyyy-mm-dd | Type | Link | Title and Presenters |
|
|
|||
| 2017-9-28 | Post Congress Symposium “Guidelines and Consensus Documents for TDM” |  |
IATDMCT Consensus Document on TDM of Everolimus Maria Shipkova |
|
|
|||
| 2017-9-28 | Post Congress Symposium “Guidelines and Consensus Documents for TDM” | |
Guidelines on Therapeutic Drug Monitoring of Immunosuppressive Drugs Used in Organ Transplantation in Japan Satohiro Masuda |
|
|
|||
| 2017-9-28 | Post Congress Symposium “Guidelines and Consensus Documents for TDM” | |
Analytical methods of Measurement for Immunosuppressive Drug Concentrations Pawel Kunicki |
|
|
|||
| 2017-9-28 | Post Congress Symposium “Guidelines and Consensus Documents for TDM” | |
Dried blood spot analysis: Are we ready for implementation? Christophe Stove |
|
|
|||
| 2017-9-28 | Post Congress Symposium “Guidelines and Consensus Documents for TDM” | |
Guidelines for Therapeutic Drug Monitoring of Cardiovascular Drugs Tsuyoshi Shiga |
|
|
|||
| 2017-9-28 | Post Congress Symposium “Guidelines and Consensus Documents for TDM” | |
Therapeutic Drug Monitoring of 5-Fluorouracil: An Approach Whose Time Has Come Edward Chu |
|
|
|||
| 2017-9-28 | Post Congress Symposium “Guidelines and Consensus Documents for TDM” | |
Personalizing Busulfan Exposure in Hematopoietic Cell Transplantation: Current consensus and discrepancy Erik van Maarseveen |
|
|
|||
| 2017-9-28 | Post Congress Symposium “Guidelines and Consensus Documents for TDM” | |
Guidelines for Therapeutic Drug Monitoring of Imatinib William Clarke |
| 2017-9-28 | Post Congress Symposium “Guidelines and Consensus Documents for TDM” | |
Guidelines for Therapeutic Drug Monitoring of Antiepileptic Drugs Toshiaki Sendo |
|
|
|||
IATDMCT, 4 Cataraqui Street Suite 310
Kingston, ON, K7K 1Z7, Canada
